Giovanna Liuzzo

Rome, 00168, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 241 publications

Weekly Journal Scan: SURMOUNT and MAINTAIN the summit: tirzepatide after successful bodyweight loss.

Weekly Journal Scan: SURMOUNT and MAINTAIN the summit: tirzepatide after successful bodyweight loss.

Journal: European heart journal
Published: August 20, 2026

Weekly Journal Scan: A novel electrocardiogram biomarker predicting sudden cardiac death: ready for prime time?

Weekly Journal Scan: A novel electrocardiogram biomarker predicting sudden cardiac death: ready for prime time?

Journal: European heart journal
Published: July 31, 2026

Weekly Journal Scan: Genetic insights into glucagon-like peptide 1 receptor agonist response, toward precision obesity therapy.

Weekly Journal Scan: Genetic insights into glucagon-like peptide 1 receptor agonist response, toward precision obesity therapy.

Journal: European heart journal
Published: July 21, 2026

Weekly Journal Scan: Not all direct oral anticoagulants are created equal.

Weekly Journal Scan: Not all direct oral anticoagulants are created equal.

Journal: European heart journal
Published: June 19, 2026

Weekly Journal Scan: an OCEANIC wave redefines the role of factor XIa inhibition in stroke prevention.

Weekly Journal Scan: an OCEANIC wave redefines the role of factor XIa inhibition in stroke prevention.

Journal: European heart journal
Published: June 01, 2026

Weekly Journal Scan: Is left atrial appendage closure really non-inferior to anticoagulation in atrial fibrillation?

Weekly Journal Scan: Is left atrial appendage closure really non-inferior to anticoagulation in atrial fibrillation?

Journal: European heart journal
Published: May 08, 2026

Weekly Journal Scan: The ebony and IVORY of modulating inflammation in acute coronary syndromes.

Weekly Journal Scan: The ebony and IVORY of modulating inflammation in acute coronary syndromes.

Journal: European heart journal
Published: May 05, 2026

Global prevalence of elevated high-sensitivity C-reactive protein in patients with atherosclerotic cardiovascular disease, with and without chronic kidney disease: findings from the POSEIDON study.

Global prevalence of elevated high-sensitivity C-reactive protein in patients with atherosclerotic cardiovascular disease, with and without chronic kidney disease: findings from the POSEIDON study.

Journal: Atherosclerosis
Published: April 23, 2026

Heart Failure and Cancer: Incidence and Mortality Patterns, A Systematic Review and Meta-analysis.

Heart Failure and Cancer: Incidence and Mortality Patterns, A Systematic Review and Meta-analysis.

Journal: European journal of heart failure
Published: April 03, 2026

A quantitative method to estimate free interleukin-6 among patients treated with the interleukin-6 ligand inhibitor ziltivekimab: comparison to C-reactive protein with implications for the ZEUS, HERMES, and ARTEMIS cardiovascular outcomes trials.

A quantitative method to estimate free interleukin-6 among patients treated with the interleukin-6 ligand inhibitor ziltivekimab: comparison to C-reactive protein with implications for the ZEUS, HERMES, and ARTEMIS cardiovascular outcomes trials.

Journal: Atherosclerosis
Published: March 31, 2026

High-sensitivity C-reactive protein as a prognostic biomarker in cardiovascular diseases: implications for atherosclerosis, chronic kidney disease, and heart failure - a review.

High-sensitivity C-reactive protein as a prognostic biomarker in cardiovascular diseases: implications for atherosclerosis, chronic kidney disease, and heart failure - a review.

Journal: Trends in cardiovascular medicine
Published: March 31, 2026

Weekly Journal Scan: Tirzepatide did not SURPASS the cardiovascular benefits of dulaglutide in type 2 diabetes.

Weekly Journal Scan: Tirzepatide did not SURPASS the cardiovascular benefits of dulaglutide in type 2 diabetes.

Journal: European heart journal
Published: March 25, 2026
Showing 1-12 of 241

Last Updated: 09/26/2026